BRANFORD, Conn., Oct. 15, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that Travis Whitfill Ph.D., Co-Founder and Chief Operating Officer will...
Hence then, the article about azitra to participate in dermatologic rare disease panel at maxim growth summit was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Azitra to Participate in Dermatologic Rare Disease Panel at Maxim Growth Summit )
Also on site :
- Education technology on rise in Japan to ease teachers' burden
- Xerox set to reduce its workforce after acquiring the company Lexmark
- Skelton: Katie Porter’s meltdown opens the door for this L.A. Democrat